| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.13B | — | +13.3% |
| Cost of Revenue | $2.57B | — | +13.5% |
| Gross Profit | $8.56B | — | +13.2% |
| R&D Expense | $1.63B | — | +11.4% |
| SG&A Expense | $740.0M | — | +6.2% |
| Operating Income | $2.35B | — | +20.9% |
| Pre-tax Income | $2.72B | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.94B | +21.9% | -18.2% |
| Accounts Receivable | $5.08B | -64.6% | +16.7% |
| Current Assets | $21.61B | -23.4% | -16.4% |
| Total Assets | $106.68B | -5.0% | +8.2% |
| Current Liabilities | $27.50B | -25.9% | +13.7% |
| Long-term Debt |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $6.70B | — | +3.5% |
| Capital Expenditures | $145.0M | — | -19.0% |
| Investing Cash Flow | -$2.18B | — | -39.3% |
| Financing Cash Flow | -$2.92B | — | -0.0% |
| Free Cash Flow | $6.56B | — | +4.1% |
| +37.8% |
| Income Tax | $614.0M | — | +41.8% |
| Net Income | $2.11B | — | +36.7% |
| EPS (Basic) | $2.43 | — | +50.9% |
| EPS (Diluted) | $2.42 | — | +52.2% |
| $39.28B |
| +172.0% |
| +365.7% |
| Total Liabilities | $72.44B | +36.3% | +90.9% |
| Stockholders' Equity | $34.23B | -42.1% | -43.6% |